Printer Friendly

GULL LABS SETS SHAREHOLDERS' MEETING

 GULL LABS SETS SHAREHOLDERS' MEETING
 SALT LAKE CITY, June 10 /PRNewswire/ -- Gull Laboratories Inc.


(NASDAQ: GULL), a Salt Lake City-based manufacturer and marketer of diagnostic test kits and health products, has scheduled its annual shareholders' meeting for June 24 at 3:30 p.m. at the company's headquarters in Salt Lake City.
 In addition to the election of the board of directors and other business, company spokesmen will report on Gull's progress in the first half of 1992 and outline programs that have been targeted for the rest of the year and for 1993 through 1995. "We are on track for the first two quarters," said Milton G. Adair, CEO, "and recent developments are allowing us to set our sights even higher. The overhaul of our marketing efforts is producing very satisfactory results." Until recently, Gull promoted its products to domestic customers directly, without the benefit of sales representatives. In 1992 the company established a network of manufacturers' representatives and obtained two major OEM distribution agreements. The distribution network for export markets is also being strengthened and expanded.
 Founded in 1974, Gull Laboratories develops, manufactures and markets high-quality diagnostic test kits for the detection of infectious diseases. The company markets these products for use in hospitals and clinical laboratories around the world. In addition, Gull manufactures natural medicines and performs health product packaging for the natural health products market.
 -0- 6/10/92
 /CONTACT: Peter Van Duser of Gull Laboratories, 801-263-3524; or John Metzger of Metzger Associates, 303-786-7000, for Gull Laboratories/
 (GULL) CO: Gull Laboratories Inc. ST: Utah IN: HEA SU:


MC -- DV004 -- 8853 06/10/92 13:17 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 10, 1992
Words:270
Previous Article:EMERGENCY VITAMINS DONATED BY SPI PHARMACEUTICALS HEADED FOR BOSNIA AND HERZEGOVINA
Next Article:WANG SUES MAJOR JAPANESE SIMM MAKERS
Topics:


Related Articles
GULL LABS NAMES NEW PRODUCT DEVELOPMENT DIRECTOR
GULL LABS REPORTS 1991 SALES OF $6.9 MILLION
GULL LABS RECEIVES FDA CLEARANCE FOR RESPIRATORY INFECTION TESTS
GULL LABORATORIES FORMS NEW MANUFACTURING, DISTRIBUTION UNIT
GULL LABS' CHAGAS' TEST RECEIVES FDA CLEARANCE
GULL LABORATORIES REPORTS CLIMB IN FIRST HALF SALES AND EARNINGS
GULL LABS SETS EUROPEAN MEDICAL DIAGNOSTICS CONFERENCE
GULL LABORATORIES' CONTROLLING INTEREST BOUGHT BY FRESENIUS
GULL LABS REPORTS 2ND QUARTER RESULTS
American Biogenetic Sciences, Inc. and Gull Laboratories, Inc. Announce Strategic Alliance on Product Manufacture and Distribution

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters